Lu-177-Lilotomab Satetraxetan (Betalutin)
Betalutin™ is the brand name of an anti-CD37 antibody labeled [...]
Betalutin™ is the brand name of an anti-CD37 antibody labeled [...]
177Lu-TLX250 (177Lu-Lutarex®, 177Lu-Girentuximab), a Lutetium-177-labeled monoclonal antibody is being developed [...]
177Lu-Edotreotide (177Lu--Octreotide, 177Lu-Solucin®) is a radiolabeled somatostatin analogue developed [...]
177Lu-IPN-01087 (177Lu-3BP-227) is a neurotensin antagonist peptide labeled with 177Lu [...]
166Ho-Phytate (Holmium-166-Phytate) was developed as an iv radiotherapeutic for the [...]
153Sm-DOTMP (153Sm-CycloSAM) is a bone pain palliation agent under [...]
131I-TM601 (131I-Chlorotoxin) is a synthetic radiolabeled peptide with anti-angiogenic activity [...]
131I-CLR 131 (131I-CLR-1404, 131I-NM404) is a small molecule, an alkyl [...]
131I-Apamistamab (131I-BC8, Iomab-B™) is an anti-CD45 radioimmunotherapy for the [...]
188Re-Etidronate (188Re-HEDP) is a therapeutic agent for bone metastases treatment. [...]